Huntsworth (LON:HNT) had its price target raised by Berenberg Bank from GBX 120 ($1.57) to GBX 125 ($1.63) in a report issued on Thursday morning, ThisIsMoney.Co.Uk reports. The firm currently has a buy rating on the stock.
HNT has been the subject of several other reports. Peel Hunt restated a buy rating on shares of Huntsworth in a report on Tuesday, March 5th. Numis Securities restated a buy rating and issued a GBX 165 ($2.16) price target on shares of Huntsworth in a report on Thursday, May 9th.
Shares of Huntsworth stock opened at GBX 101 ($1.32) on Thursday. Huntsworth has a 1 year low of GBX 76.60 ($1.00) and a 1 year high of GBX 140 ($1.83). The stock has a market capitalization of $352.45 million and a price-to-earnings ratio of 16.56. The company has a quick ratio of 1.29, a current ratio of 1.46 and a debt-to-equity ratio of 50.92.
Huntsworth Company Profile
Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams.
Further Reading: Are sell-side analysts objective?
Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.